ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1923

Single Cell RNA Sequencing Reveals a Signature of Endothelial Injury in Scleroderma Skin

Sokratis Apostolidis1, Giuseppina Stifano2, Tracy Tabib3, Lisa Rice2, Christina Morse3, Bashar Kahaleh4 and Robert A. Lafyatis3, 1Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, 2Boston University School of Medicine, Boston, MA, 3Medicine, Rheumatology, University of Pittsburgh Medical Center, Pittsburgh, PA, 4Medicine/Rheumatology, University of Toledo, Toledo, OH

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: endothelial cells, scleroderma and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics I

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Vascular injury is a hallmark event in the pathogenesis of Systemic Sclerosis (SSc). Endothelial dysfunction happens early in the course of the disease and drives some of the most prominent clinical manifestations of scleroderma, including Raynaud’s phenomenon, telangiectasias and gastric antral vascular ectasias, pulmonary arterial hypertension and scleroderma renal crisis. The exact mechanisms that lead to endothelial cell injury and propagate the vasculopathy in scleroderma are not well understood. Single cell RNA sequencing provides a robust platform for cellular identification, allows gene expression analysis at the single cell level and accounts for cellular heterogeneity.

Methods:

The study was completed in the Scleroderma Center of UPMC in collaboration with the Scleroderma Research Center of Boston University and the Broad Institute of Boston. We implemented single cell sorting and subsequent RNA sequencing of cells isolated from scleroderma and healthy control skin. The analysis was performed using R software. We used t-distributed stochastic neighbor embedding (t-SNE) with k-means clustering to identify the various cell types. We performed pathway analysis using Gene Set Enrichment Analysis (GSEA) and Ingenuity Pathway Analysis (IPA). Finally, we independently verified distinct markers using immunohistochemistry on skin biopsies and qPCR in primary endothelial cells isolated from skin of scleroderma patients and healthy controls.

Results:

In order to visualize and ultimately define the various cell subsets in the single cell RNA sequencing dataset, we used t-SNE analysis, a method of unsupervised learning for dimensionality reduction. 2D projection of the t-SNE coupled with k-means clustering effectively reduced the dimensionality of the data. By combining the t-SNE analysis with the expression of known endothelial cell markers, including VWF, PECAM1 and CDH5, we were able to positively identify the endothelial cells among the sorted single cells from healthy and scleroderma skin. Subsequently, we analyzed the differential expression profile between the endothelial cells from healthy and scleroderma skin. Using GSEA and IPA analysis, we were able to demonstrate that the SSc endothelial cell expression profile is enriched in processes associated with extracellular matrix generation, negative regulation of angiogenesis and epithelial-to-mesenchymal transition. Finally, two of the top differentially expressed genes, HSPG2 and APLNR, were independently verified. Primary endothelial cells isolated from scleroderma skin expressed higher levels of APLNR mRNA compared to endothelial cells isolated from healthy skin. Immunohistochemistry studies of skin biopsies revealed that HSPG2 showed increased expression in the perivascular area of scleroderma skin compared to healthy skin.

Conclusion:

Using single cell RNA sequencing we were able to identify an endothelial cell gene signature in scleroderma skin. Differential gene expression and pathway analysis revealed that endothelial cells from scleroderma patients exhibit a pattern of endothelial injury and activation as well as increased extracellular matrix generation and negative regulation of angiogenesis.


Disclosure: S. Apostolidis, None; G. Stifano, None; T. Tabib, None; L. Rice, None; C. Morse, None; B. Kahaleh, None; R. A. Lafyatis, None.

To cite this abstract in AMA style:

Apostolidis S, Stifano G, Tabib T, Rice L, Morse C, Kahaleh B, Lafyatis RA. Single Cell RNA Sequencing Reveals a Signature of Endothelial Injury in Scleroderma Skin [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/single-cell-rna-sequencing-reveals-a-signature-of-endothelial-injury-in-scleroderma-skin/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-rna-sequencing-reveals-a-signature-of-endothelial-injury-in-scleroderma-skin/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology